a drug company
Industry Biotechnology
A.I.dvisor tells us that CRIS and INKT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRIS and INKT's prices will move in lockstep.
Ticker / NAME | Correlation To CRIS | 1D Price Change % | ||
---|---|---|---|---|
CRIS | 100% | -0.86% | ||
INKT - CRIS | 29% Poorly correlated | -7.12% | ||
BDTX - CRIS | 27% Poorly correlated | -5.30% | ||
AVIR - CRIS | 27% Poorly correlated | +1.94% | ||
RARE - CRIS | 26% Poorly correlated | -0.99% | ||
RCKT - CRIS | 26% Poorly correlated | +1.36% | ||
More |